1. The management of posttransplant lymphoproliferative disorder

   • Noelle V. Frey
   • Donald E. Tsai

   Review Pages: 125 - 136

2. A general review of the role of irinotecan (CPT11) in the treatment of gastric cancer

   • Fadi Sami Farhat

   Review Pages: 137 - 146

3. Phase I/II study of IV topotecan in combination with whole brain radiation for the treatment of brain metastases

   • Alireza Mirmiran
   • Edward McClay
   • Matthew A. Spear

   Original Article Pages: 147 - 153

4. Risk factors for central nervous system metastasis in patients with metastatic breast cancer

   • Canfeza Sezgin
   • Erhan Gokmen
   • Erdem Goker

   Original Article Pages: 155 - 161

5. Serum IL-8 and IL-12 levels in breast cancer

   • Duygu Derin
   • Hilal Oguz Soydinc
   • Erkan Topuz

   Original Article Pages: 163 - 168

6. Expression of c-kit proto-oncogene product in breast cancer tissues

   • Aydan Eroğlu
   • Aliye Sari

   Original Article Pages: 169 - 174

7. Long-term complications of platinum-based chemotherapy in testicular cancer survivors

   • J. H. Oh
   • D. D. Baum
   • I. Chen

   Review Pages: 175 - 181

8. Inhibitory effects of a nutrient mixture on human testicular cancer cell line NT 2/DT matrigel invasion and MMP activity

   • M. Waheed Roomi
   • Vadim Ivanov
   • Matthias Rath

   Original Article Pages: 183 - 188

9. Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

   • Marvin Rubenstein
   • Paulus Tsui
   • Patrick Guinan

   Original Article Pages: 189 - 196

10. Thymic epithelial neoplasia

    • Emin Tamer Elkiran
    • Huseyin Abali
    • Yavuz Ozisik

    Original Article Pages: 197 - 201

11. Outcomes of primary thyroid non-Hodgkin’s Lymphoma

    • Milica Čolović
    • Slavko Matić
    • Henry Dushan Edward Atkinson

    Original Article Pages: 203 - 208

12. Naturally produced extracellular matrix inhibits growth rate and invasiveness of human osteosarcoma cancer cells

    • V. Ivanov
    • S. Ivanova
    • M. Rath

    Original Article Pages: 209 - 217

13. CEA levels in serum and BAL in patients suffering from lung cancer

    • Konstantinos Charalabopoulos
    • Agathi Karakosta
    • Anna Batistatou

    Original Pages: 219 - 225

14. Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma

    • Agustin Avilés
    • María J. Nambo
    • Judith Huerta-Guzmán

    Original Pages: 227 - 230

15. Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture

    • M. Waheed Roomi
    • Vadim Ivanov
    • Matthias Rath

    Original Article Pages: 231 - 238

16. Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer

    • Mustafa Cengiz
    • Faruk Zorlu
    • Ibrahim H. Gullu

    Original Article Pages: 239 - 243

17. Adrenomedullin expression does not correlate with survival in lung cancer

    • S. Buyukberber
    • I. Sari
    • H. M. Turk

    Origanal Article Pages: 245 - 249

18. DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU

    • Hong Zhang
    • You-Ming Li
    • Xi Jin

    Original Article Pages: 251 - 258

19. Infusional 5-fluorouracil and cisplatin as first-line chemotherapy in patients with carcinoma of unknown primary site

    • Hitoshi Kusaba
    • Yoshihiro Shibata
    • Shuji Nakano

    Original Article Pages: 259 - 264

20. A tribute to Professor Roberto De Bellis

    • Pablo Muxi
    • Peter H. Wiernik

    Obituary Pages: 265 - 265